Cargando…

Association of Second-generation Antiandrogens With Depression Among Patients With Prostate Cancer

IMPORTANCE: Previous studies have shown a consistent association between hormone therapy (HT), such as androgen deprivation therapy, to treat prostate cancer and depression risk. However, the association between second-generation antiandrogens (AAs) and depression is unknown. OBJECTIVE: To test the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowakowska, Malgorzata K., Lei, Xiudong, Wehner, Mackenzie R., Corn, Paul G., Giordano, Sharon H., Nead, Kevin T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703250/ https://www.ncbi.nlm.nih.gov/pubmed/34940861 http://dx.doi.org/10.1001/jamanetworkopen.2021.40803

Ejemplares similares

Association of Endocrine Therapy and Dementia in Women with Breast Cancer
por: Thompson, Mikayla R, et al.
Publicado: (2021)

Rational Second-Generation Antiandrogen Use in Prostate Cancer
por: Orme, Jacob J, et al.
Publicado: (2022)

Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
por: Verma, Shiv, et al.
Publicado: (2020)

Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
por: Semenas, Julius, et al.
Publicado: (2013)

Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US
por: Sosa, Alan, et al.
Publicado: (2022)

Estimated Projection of US Cancer Incidence and Death to 2040
por: Rahib, Lola, et al.
Publicado: (2021)

Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
por: Rice, Meghan A., et al.
Publicado: (2019)

Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives
por: Pinto, Francesco, et al.
Publicado: (2022)

Risk of Cancer After Diagnosis of Cardiovascular Disease
por: Bell, Caitlin F., et al.
Publicado: (2023)

Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second‐line antiandrogen therapy era
por: Kim, Isaac E., et al.
Publicado: (2021)

Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer
por: Suarez-Almazor, Maria E., et al.
Publicado: (2022)

Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta‐analysis
por: Nowakowska, Malgorzata K., et al.
Publicado: (2022)

Comparison of the Proportions of Female and Male Corresponding Authors in Preprint Research Repositories Before and During the COVID-19 Pandemic
por: Wehner, Mackenzie R., et al.
Publicado: (2020)

Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair
por: Elsesy, Mohamed E., et al.
Publicado: (2020)

Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
por: Maitland, Norman J.
Publicado: (2021)

Plenty of moustaches but not enough women: cross sectional study of medical leaders
por: Wehner, Mackenzie R, et al.
Publicado: (2015)

Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide
por: Hoefer, Julia, et al.
Publicado: (2016)

Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants – In vivo evidence
por: Özten-Kandaş, Nur, et al.
Publicado: (2011)

Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
por: Boudadi, Karim, et al.
Publicado: (2016)

Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade
por: Flaig, Thomas W., et al.
Publicado: (2017)

Role of prostate cancer stem-like cells in the development of antiandrogen resistance
por: Kushwaha, Prem Prakash, et al.
Publicado: (2022)

Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy
por: Congregado Ruiz, Belén, et al.
Publicado: (2023)

Assessment of Second-Generation Diabetes Medication Initiation Among Medicare Enrollees From 2007 to 2015
por: Gilstrap, Lauren G., et al.
Publicado: (2020)

Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment
por: Portet, Sylvain, et al.
Publicado: (2019)

Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
por: Zhang, Zeda, et al.
Publicado: (2020)

Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?
por: Yekedüz, Emre, et al.
Publicado: (2021)

Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment
por: Besançon, Marjorie, et al.
Publicado: (2022)

Second-Generation Drosophila Chemical Tags: Sensitivity, Versatility, and Speed
por: Sutcliffe, Ben, et al.
Publicado: (2017)

Self-Reported History of Childhood Smoking Is Associated with an Increased Risk for Peripheral Arterial Disease Independent of Lifetime Smoking Burden
por: Priest, James R., et al.
Publicado: (2014)

Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models
por: SQUILLACE, RACHEL M., et al.
Publicado: (2012)

MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance
por: Ottman, Richard, et al.
Publicado: (2014)

Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer Treatment
por: Ivachtchenko, Alexandre V., et al.
Publicado: (2014)

Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells
por: Brooke, Greg N., et al.
Publicado: (2015)

Evolution of Electrocardiographic Repolarization Parameters During Antiandrogen Therapy in Patients with Prostate Cancer and Hypogonadism
por: Gheorghe, Andrei Cristian Dan, et al.
Publicado: (2020)

The impact of antiandrogen 2-hydroxyflutamide on the expression of steroidogenic enzymes in cultured porcine ovarian follicles
por: Duda, Malgorzata, et al.
Publicado: (2014)

Advantage of soybean isoflavone as antiandrogen on acne vulgaris
por: Riyanto, Puguh, et al.
Publicado: (2015)

Efficacy of Alternative Antiandrogen Therapy for Prostate Cancer That Relapsed after Initial Maximum Androgen Blockade
por: Choi, Joon Il, et al.
Publicado: (2011)

GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance
por: Lee, Eugine, et al.
Publicado: (2019)

Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer
por: Wu, Meng, et al.
Publicado: (2023)

Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis
por: Sun, Rui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q0pnemhlhi697n7kiajlnbd77o